179 related articles for article (PubMed ID: 16125305)
1. Nuclear factor-kappaB and liver carcinogenesis.
Arsura M; Cavin LG
Cancer Lett; 2005 Nov; 229(2):157-69. PubMed ID: 16125305
[TBL] [Abstract][Full Text] [Related]
2. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
[TBL] [Abstract][Full Text] [Related]
3. Contradictory functions of NF-kappaB in liver physiology and cancer.
Vainer GW; Pikarsky E; Ben-Neriah Y
Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
Elsharkawy AM; Mann DA
Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB and cancer: mechanisms and targets.
Karin M
Mol Carcinog; 2006 Jun; 45(6):355-61. PubMed ID: 16673382
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation.
Chung C; Park SG; Park YM; Joh JW; Jung G
Cancer Sci; 2007 Nov; 98(11):1758-66. PubMed ID: 17711513
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
Zhang Z; Rigas B
Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and cancer: role of nuclear factor-kappaB activation.
Maeda S; Omata M
Cancer Sci; 2008 May; 99(5):836-42. PubMed ID: 18294278
[TBL] [Abstract][Full Text] [Related]
11. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
12. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
[TBL] [Abstract][Full Text] [Related]
13. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
15. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
16. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
17. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
